ALZN Alzamend Neuro
Alzamend Neuro earnings company data as of 4:46 AM ET 11/22
Scheduled
2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2027 Q2 | 8 Dec | EPS | -0.23 | — | — |
| Rev | — | — | — | ||
| FY2027 Q1 | 10 Sep | EPS | -0.56 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by ALZN's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $111K bought by 1 insider
- $14K sold by 2 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Milton C. Ault III DirectorSale$3,116 2,000 shares at $1.56 100% of stakeTraded Aug 26 Filed Aug 31
-
Milton C. Ault III DirectorBuy$111K 110,388 shares at $1.01Traded Apr 14 Filed Aug 31
-
Milton C. Ault III DirectorSale$3,825 1,851 shares at $2.07 100% of stakeTraded Dec 23, 2025 Filed Dec 30, 2025
-
William B. Horne DirectorSale$7,059 3,333 shares at $2.12 100% of stakeTraded Dec 19, 2025 Filed Dec 23, 2025
-
Lynne Fahey McGrath DirectorSale$69 30 shares at $2.29 55% of stakeTraded Oct 23, 2025 Filed Oct 24, 2025
-
Milton C. Ault III DirectorSale$295K 121,791 shares at $2.42 94% of stakeTraded Oct 8–9 Filed Oct 10, 2025
-
Milton C. Ault III DirectorSale$344K 139,412 shares at $2.47 67% of stakeTraded Oct 6–7 Filed Oct 8, 2025
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K/A | 1.01,3.02,5.03,9.01 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 10-Q | Period Jul 31, 2026 | Filing Doc | |
| S-1 | — | Filing Doc | |
| 8-K | 1.01,3.01,3.02,5.03,9.01 | Filing Doc | |
| 10-K | Period Apr 30, 2026 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 5.07,9.01 | Filing Doc | |
| 8-K | 3.01,9.01 | Filing Doc | |
| 10-Q | Period Jan 31, 2026 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 424B5 | — | Filing Doc | |
| DEF 14A | Period Apr 17, 2026 | Filing Doc | |
| DEFA14A | — | Filing Doc | |
| 10-Q | Period Oct 31, 2025 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 5.03,9.01 | Filing Doc | |
| 8-K | 3.02,9.01 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 3.02,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon
- Financial Intelligence, Revised Ed. View on Amazon